BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3438170)

  • 1. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
    Feldman JM; Blinder RA; Lucas KJ; Coleman RE
    J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine.
    Bomanji J; Levison DA; Zuzarte J; Britton KE
    J Nucl Med; 1987 Dec; 28(12):1907-10. PubMed ID: 3681447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy.
    Adolph JM; Kimmig BN; Georgi P; zum Winkel K
    Radiology; 1987 Jul; 164(1):199-203. PubMed ID: 3588904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
    Siproudhis L; Lescouarc'h J; Bretagne JF; Bourguet P; Raoul JL; Etienne PL; Herry JY; Gosselin M
    Gastroenterol Clin Biol; 1991; 15(11):789-93. PubMed ID: 1769467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
    Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical relevance of I-123/I-131-MIBG scintigraphy in intestinal carcinoid tumors].
    van de Flierdt E; Frank T; Laubenbacher C; Fink U; Bauer R; Langhammer HR; Pabst HW
    Nuklearmedizin; 1998 Jun; 37(4):129-33. PubMed ID: 9650212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
    Dresel S; Tatsch K; Zachoval R; Hahn K
    Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
    Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE
    Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoid tumors: iodine-131 MIBG scintigraphy.
    Hanson MW; Feldman JM; Blinder RA; Moore JO; Coleman RE
    Radiology; 1989 Sep; 172(3):699-703. PubMed ID: 2772175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
    Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
    Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
    Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
    Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of radioiodinated MIBG for neural crest tumors in childhood.
    Leung A; Shapiro B; Hattner R; Kim E; de Kraker J; Ghazzar N; Hartmann O; Hoefnagel CA; Jamadar DA; Kloos R; Lizotte P; Lumbroso J; Rufini V; Shulkin BL; Sisson JC; Thein A; Troncone L
    J Nucl Med; 1997 Sep; 38(9):1352-7. PubMed ID: 9293786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.
    Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M
    Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.